EPISODE · Sep 25, 2025 · 22 MIN
How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid
from Oncology Brothers: Practice-Changing Cancer Discussions · host Oncology Brothers
In this episode of the Oncology Brothers podcast, we are joined by Dr. Omid Hamid, a melanoma specialist from Cedars-Sinai, to explore the current treatment landscape of cutaneous melanoma.We covered a wide range of topics, including:• The standard of care for early-stage melanoma, including wide local excision and sentinel lymph node evaluation.• The role of adjuvant immunotherapy and BRAF/MEK inhibitors for high-risk patients.• Insights into neoadjuvant treatment options for resectable disease, including recent trial data from NADINA and SWOG S1808.• The importance of next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) in treatment planning and monitoring.• The evolving treatment paradigm for metastatic melanoma, including the use of dual checkpoint inhibitors and BRAF/MEK inhibitors.Join us as we discuss the latest advancements in melanoma treatment and the critical role of patient education and shared decision-making in oncology care.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to subscribe for more episodes on treatment algorithms, new FDA approvals, and conference highlights!#Melanoma #Immunotherapy #BRAF #ctDNA #Neoadjuvant #OncologyBrothers
What this episode covers
In this episode of the Oncology Brothers podcast, we are joined by Dr. Omid Hamid, a melanoma specialist from Cedars-Sinai, to explore the current treatment landscape of cutaneous melanoma.We covered a wide range of topics, including:• The standard of care for early-stage melanoma, including wide local excision and sentinel lymph node evaluation.• The role of adjuvant immunotherapy and BRAF/MEK inhibitors for high-risk patients.• Insights into neoadjuvant treatment options for resectable disease, including recent trial data from NADINA and SWOG S1808.• The importance of next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) in treatment planning and monitoring.• The evolving treatment paradigm for metastatic melanoma, including the use of dual checkpoint inhibitors and BRAF/MEK inhibitors.Join us as we discuss the latest advancements in melanoma treatment and the critical role of patient education and shared decision-making in oncology care.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to subscribe for more episodes on treatment algorithms, new FDA approvals, and conference highlights!#Melanoma #Immunotherapy #BRAF #ctDNA #Neoadjuvant #OncologyBrothers
NOW PLAYING
How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m